Commission Implementing Decision (EU) 2022/137 of 28 January 2022 concerning the extension of the action taken by the Health and Safety Executive of the United Kingdom permitting the making available on the market and use of the biocidal product Mydis in accordance with Article 55(1) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2022) 408) (Only the English text is authentic)

CELEX: 32022D0137
Document type: DEC_IMPL
Sector: Legislation
Date of document: 2022-01-28
In force since: 2022-01-31
Status: In force
ELI: http://data.europa.eu/eli/dec_impl/2022/137/oj

Text

Article-level text, parsed from the formex manifestation.

Article 1

The Health and Safety Executive of the United Kingdom, acting on behalf of the Health and Safety Executive for Northern Ireland, may extend until 23 February 2023 the action to permit the making available on the market and use of the biocidal product Mydis, in the United Kingdom in respect of Northern Ireland.

Article 2

This Decision is addressed to the Health and Safety Executive of the United Kingdom, acting on behalf of the Health and Safety Executive for Northern Ireland. It shall apply from 22 August 2021.

Relations

What this act cites, and what cites it.

Show relations

Versions

Point-in-time consolidated versions of this act.

Show versions